Pain of endometriosis: effects of nafarelin and danazol therapy
RCT
OA: closed
CC0
⤵ 31 in-corpus citations
AI-generated summary
Nafarelin acetate and danazol were equally effective in relieving endometriosis-associated pain for up to six months after treatment completion.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
OBJECTIVE: To compare the efficacy of nafarelin acetate with danazol in the treatment of dysmenorrhea, dyspareunia, and pelvic pain associated with endometriosis.
DESIGN: Prospective, randomized double-blind controlled study. PATIENTS, SETTING, TREATMENTS: Two hundred thirteen patients aged 18 to 48 with laparoscopically confirmed pelvic endometriosis and dysmenorrhea, dyspareunia or pelvic pain were randomly assigned to 6 months of treatment with either nafarelin acetate 800 micrograms per day or 400 micrograms per day, or danazol 800 micrograms per day.
MAIN OUTCOME MEASURES: The percentage of patients with dysmenorrhea, dyspareunia or pelvic pain before treatment who still had these symptoms after 6 months of treatment and 6 months following completion of treatment. RESULTS [table: see text]
CONCLUSIONS: Nafarelin acetate and danazol both provided significant relief of dysmenorrhea, dyspareunia, and pelvic pain during treatment and for 6 months following treatment in women with endometriosis.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
Cited by (29)
- A systematic literature review on patient-reported outcome domains and measures in nonsurgical efficacy trials related to chronic pain associated with endometriosis: an urgent call to action 2024
- Gonadotropin-releasing hormone analogues for endometriosis 2023
- A review of phase II and III drugs for the treatment and management of endometriosis 2023
- Danazol 2022
- Hormonal Therapy in Endometriosis and Adenomyosis: Danazol, Aromatase Inhibitors 2022
- Adolescent Endometriosis 2020
- Medical therapy options for endometriosis related pain, which is better? A systematic review and network meta-analysis of randomized controlled trials 2020
- A comprehensive review of hormonal and biological therapies for endometriosis: latest developments 2019
- No 164 - Directive clinique de consensus pour la prise en charge de la douleur pelvienne chronique 2018
- Current and Emerging Therapeutics for the Management of Endometriosis 2018
- Reevaluating response and failure of medical treatment of endometriosis: a systematic review 2017
- Treatment of pain associated with deep endometriosis: alternatives and evidence 2015
- The Place of Gonadotropin-Releasing Hormone Agonists in the Management of Endometriosis 2014
- Ovarian hormones and chronic pain: A comprehensive review 2014
- Integrated pharmacometrics and systems pharmacology model-based analyses to guide GnRH receptor modulator development for management of endometriosis 2012
- Gonadotrophin-releasing hormone analogues for pain associated with endometriosis 2010
- Pentoxifylline after conservative surgery for endometriosis: a randomized, controlled trial 2008
- Noninvasive assessment of ectopic uterine tissue development in rats using magnetic resonance imaging 2007
- Management of the pain associated with endometriosis: an update of the painful problems 2006
- GnRH analogs: options for endometriosis-associated pain treatment 2006
- Optimizing gonadotropin-releasing hormone agonist therapy in women with endometriosis 2004
- Chronic pelvic pain 2003
- Tratamiento de la endometriosis y medicina basada en la evidencia 2003
- The treatment of endometriosis: a review of the evidence 2002
- Consensus statement for the management of chronic pelvic pain and endometriosis: proceedings of an expert-panel consensus process 2002
- Medical and surgical therapies for pain associated with endometriosis 2001
- WITHDRAWN: Gonadotrophin-releasing hormone analogues for pain associated with endometriosis 1999
- Current drug therapy recommendations for the treatment of endometriosis 1999
- Gonadotrophin-releasing hormone analogues for pain associated with endometriosis 1999
Source provenance
- europepmc
- last seen: 2026-10-15T06:08:49.021275+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-10-08T21:59:14.651011+00:00
License: CC0
· commercial use OK